Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NextCure, Inc. Director's Dealing 2019

May 14, 2019

35069_dirs_2019-05-13_f3548f37-a8da-4343-80da-935ec3a9edb2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NextCure, Inc. (NXTC)
CIK: 0001661059
Period of Report: 2019-05-13

Reporting Person: Khuong Chau Quang (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-05-13 Common Stock C 445866 Acquired 445866 Indirect
2019-05-13 Common Stock C 743110 Acquired 1188976 Indirect
2019-05-13 Common Stock C 729599 Acquired 1918575 Indirect
2019-05-13 Common Stock C 442438 Acquired 2361013 Indirect
2019-05-13 Common Stock P 350000 $15.00 Acquired 2711013 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-05-13 Series A-1 Preferred Stock $ C 3582000 Disposed Common Stock (445866) Indirect
2019-05-13 Series A-2 Preferred Stock $ C 5970000 Disposed Common Stock (743110) Indirect
2019-05-13 Series A-3 Preferred Stock $ C 5861455 Disposed Common Stock (729599) Indirect
2019-05-13 Series B-1 Preferred Stock $ C 3554466 Disposed Common Stock (442438) Indirect

Footnotes

F1: The reported securities automatically converted into shares of Common Stock on a 1-for-8.0338 basis upon the closing of the Issuer's initial public offering and had no expiration date.

F2: OrbiMed Capital GP VI LLC ("GP VI") is the sole general partner of OrbiMed Private Investments VI, LP ("OPI VI"). OrbiMed Advisors LLC ("OrbiMed Advisors") is the managing member of GP VI. By virtue of such relationships, GP VI and OrbiMed Advisors may be deemed to have voting and investment power with respect to the shares held by OPI VI and as a result may be deemed to have beneficial ownership of such shares. The Reporting Person is an employee of OrbiMed Advisors. OrbiMed Advisors exercises investment and voting power through a management committee comprised of Carl L. Gordon, Sven H. Borho and Jonathan T. Silverstein. Each of GP VI, OrbiMed Advisors and the Reporting Person disclaims beneficial ownership of the shares held by OPI VI, except to the extent of its or his pecuniary interest therein, if any.